PKLR
PKLR (pyruvate kinase L/R, previously pyruvate kinase, liver and RBC) is a member of the pyruvate kinase family that catalyses the conversion of phosphoenolpyruvate to pyruvate with the synthesis of ATP. It plays a key role in glycolysis. Browse Assay Genie's current range of PKLR research reagents below, or read on for the biology behind the target.
PKLR is a pyruvate kinase that catalyses the transphosphorylation of phosphoenolpyruvate into pyruvate and ATP. This reaction is described as the rate-limiting step of glycolysis, which places the enzyme at a point of control in cellular energy metabolism. The enzyme also produces a side product, 2-phospholactate, which can inhibit the production of fructose-2,6-bisphosphate. The phosphatase PGP can dephosphorylate 2-phospholactate, which prevents this inhibition and allows glycolysis to proceed.
The PKLR gene encodes the protein listed by UniProt as pyruvate kinase PKLR, and it belongs to the pyruvate kinase family. The enzyme carries the EC number 2.7.1.40. Multiple transcript variants encoding different isoforms have been reported for this gene, so researchers studying the PKLR protein should consider which isoform is relevant to their work. Mouse and rat each have an ortholog named Pklr, which allows the enzyme to be studied in common rodent models.
The earlier HGNC name for the gene, pyruvate kinase, liver and RBC, reflects the tissues in which this enzyme was first recognised. Defects in the enzyme, whether from gene mutations or genetic variations, are a common cause of chronic hereditary nonspherocytic haemolytic anaemia (CNSHA or HNSHA). This link to a red cell disorder, together with the enzyme's role in glycolysis and the 2-phospholactate and PGP mechanism, makes PKLR a frequent subject in metabolic and haematological research.
PKLR catalyses the rate-limiting step of glycolysis, converting phosphoenolpyruvate to pyruvate with ATP synthesis.
Defects in this enzyme are a common cause of chronic hereditary nonspherocytic haemolytic anaemia.
PKLR produces 2-phospholactate, which PGP dephosphorylates to prevent inhibition of fructose-2,6-bisphosphate production.
Multiple transcript variants encode different isoforms, making PKLR relevant to studies of genetic variation and expression.
PKLR is a pyruvate kinase that catalyses the conversion of phosphoenolpyruvate to pyruvate with the synthesis of ATP, a rate-limiting step of glycolysis. It also generates 2-phospholactate as a side product, which PGP dephosphorylates so that glycolysis can continue.
HGNC lists the gene as pyruvate kinase L/R, previously named pyruvate kinase, liver and RBC. UniProt calls the protein pyruvate kinase PKLR. No other aliases are recorded. Multiple transcript variants encoding different isoforms have been described for the gene.
Defects in PKLR, due to mutations or genetic variations, are a common cause of chronic hereditary nonspherocytic haemolytic anaemia. Mouse and rat both have a Pklr ortholog; check the datasheet of any product for its validated reactivity.
Pyruvate kinase family members and glycolysis pathway partners that are relevant to PKLR research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P30613; product specifications from Assay Genie datasheets.